Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.bmt.1702679DOI Listing

Publication Analysis

Top Keywords

aspergillus tracheobronchitis
4
tracheobronchitis allogeneic
4
allogeneic bone
4
bone marrow
4
marrow transplantation
4
aspergillus
1
allogeneic
1
bone
1
marrow
1
transplantation
1

Similar Publications

Pulmonary overlap syndrome in a patient with bronchial asthma.

BMJ Case Rep

January 2025

Pulmonary, Critical Care and Sleep Medicine, ESICPGIMSR, New Delhi, Delhi, India.

Allergic bronchopulmonary aspergillosis (ABPA) is a disease of immunocompetent patients, and invasive pulmonary aspergillosis is seen in immunocompromised patients. Hence, pulmonary overlap syndrome presenting with ABPA and invasive aspergillosis is extremely rare. We report a case of well-controlled bronchial asthma who presented with acute exacerbation and hypoxaemic respiratory failure.

View Article and Find Full Text PDF
Article Synopsis
  • Tracheobronchitis (AT) is a rare but severe form of invasive pulmonary aspergillosis that occurs infrequently in HIV-infected individuals, making up only 4.5% of cases according to recent studies.
  • The use of modern antiretroviral therapy (ART) has decreased the incidence of opportunistic infections like AT in well-managed HIV patients.
  • A case study of a young woman with controlled HIV who developed AT despite her treatment highlights the importance of recognizing respiratory symptoms, as swift diagnosis and antifungal treatment are crucial for better patient outcomes.*
View Article and Find Full Text PDF
Article Synopsis
  • Invasive tracheobronchial aspergillosis (ITBA) is a serious fungal infection that affected a 75-year-old man with multiple health issues, including lung cancer and COPD.
  • The patient experienced severe breathing difficulties, and while doctors initially thought his symptoms were due to cancer recurrence, a post-mortem revealed that ITBA was the actual cause.
  • The case underscores the complexity of diagnosing ITBA, especially in patients with various risk factors, highlighting the need to consider fungal infections when diagnosing airway problems in high-risk individuals.
View Article and Find Full Text PDF

Introduction: Data on the prevalence of fungal coinfections/superinfections in patients with COVID-19 are limited.

Objective: To describe the prevalence of fungal coinfections/superinfections in patients with COVID-19, as well as risk factors and demographic, clinical, and microbiological characteristics.

Material And Methods: We included patients with a confirmed COVID-19 diagnosis and a confirmed fungal infection hospitalized in the ICU from March 2020 to December 2021.

View Article and Find Full Text PDF

Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients.

Lancet Respir Med

September 2024

Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium; Department of Internal Medicine, University Hospitals Leuven, Leuven, Belgium; Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium.

Influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) are increasingly recognised as important complications in patients requiring intensive care for severe viral pneumonia. The diagnosis can typically be made in 10-20% of patients with severe influenza or COVID-19, but only when appropriate diagnostic tools are used. Bronchoalveolar lavage sampling for culture, galactomannan testing, and PCR forms the cornerstone of diagnosis, whereas visual examination of the tracheobronchial tract during bronchoscopy is required to detect invasive Aspergillus tracheobronchitis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!